Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The Evolution of Long-Acting Antipsychotics Use in Québec between 2003 and 2017.

Literature DB >> 32030998

The Evolution of Long-Acting Antipsychotics Use in Québec between 2003 and 2017.

Abstract

Keywords: antipsychotics; long-acting injectable; long-acting injectable antipsychotics; pharmacoepidemiology; psychopharmacology; psychosis; schizophrenia; treatment

Year: 2020 PMID： 32030998 PMCID： PMC7298586 DOI： 10.1177/0706743720901975

Source DB: PubMed Journal: Can J Psychiatry ISSN： 0706-7437 Impact factor: 4.356

Keyword Cloud
References

× No keyword cloud information.

9 in total

1. [Long-acting injectable antipsychotics: an expert opinion from the Association des médecins psychiatres du Québec].

Authors: Emmanuel Stip; Amal Abdel-Baki; David Bloom; Sylvain Grignon; Marc-André Roy
Journal: Can J Psychiatry Date: 2011-06 Impact factor: 4.356

2. Prescribing trends and indications of antipsychotic medication in Hong Kong from 2004 to 2014: General and vulnerable patient groups.

Authors: Kim S J Lao; Anthony W Y Tam; Ian C K Wong; Frank M C Besag; Kenneth K C Man; Celine S L Chui; Esther W Chan
Journal: Pharmacoepidemiol Drug Saf Date: 2017-06-30 Impact factor: 2.890

3. Comparative effectiveness and safety of antipsychotic drugs in schizophrenia treatment: a real-world observational study.

Authors: A Vanasse; L Blais; J Courteau; A A Cohen; P Roberge; A Larouche; S Grignon; M-J Fleury; A Lesage; M-F Demers; M-A Roy; J-D Carrier; A Delorme
Journal: Acta Psychiatr Scand Date: 2016-07-12 Impact factor: 6.392

4. Antipsychotic long-acting injections: A community-based study from 2007 to 2014 of prescribing trends and characteristics associated with initiation.

Authors: Hélène Verdoux; Elodie Pambrun; Marie Tournier; Julien Bezin; Antoine Pariente
Journal: Schizophr Res Date: 2016-09-10 Impact factor: 4.939

The Evolution of Long-Acting Antipsychotics Use in Québec between 2003 and 2017.

1. [Long-acting injectable antipsychotics: an expert opinion from the Association des médecins psychiatres du Québec].

2. Prescribing trends and indications of antipsychotic medication in Hong Kong from 2004 to 2014: General and vulnerable patient groups.

3. Comparative effectiveness and safety of antipsychotic drugs in schizophrenia treatment: a real-world observational study.

4. Antipsychotic long-acting injections: A community-based study from 2007 to 2014 of prescribing trends and characteristics associated with initiation.

5. Medication decisions and clinical outcomes in the Canadian National Outcomes Measurement Study in Schizophrenia.

6. Long-acting injectable antipsychotics: recommendations for clinicians.

Review 7. Long-acting injectable antipsychotics: evidence of effectiveness and use.

8. Trends in Off-Label Use of Second-Generation Antipsychotics in the Medicare Population From 2006 to 2012.

9. [Long-acting antipsychotics: The QAAPAPLE algorithm review].